Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Clinical guideline published by British Association for Psychopharmacology (BAP) on
The British Association for Psychopharmacology (BAP) focuses on advancing the field of psychopharmacology through evidence-based guidelines and consensus statements. They provide resources for professionals, including guidelines on various mental health topics, enhancing clinical decision-making.